Brain+

Digital Therapeutics for Alzheimer's Disease and Dementia. Our mission is to restore patients' independence and quality of life by detecting and treating dementia with digital technologies. Brain+ is addressing one of the largest healthcare challenges of our time, namely dementia. Currently, 1 in 3 seniors die with/of dementia in the US and globally 50 million people are diagnosed with dementia – and unfortunately, this figure is expected to more than triple to 152 million people by 2050. As we generally live longer and the prevention and treatment of the most common causes of death such as cancer and heart disease are getting more efficient, dementia is expected to become a leading cause of death by 2030 and is already the leading cause of death for women in the UK. Dementia puts an enormous emotional burden on the patients and their loved ones as cognitive abilities deteriorate, behaviours change, and independence is lost. It is also a massive and increasing financial burden on society and our health care systems with an accumulated global cost upwards of 1 trillion USD globally today and expected to double to 2 trillion USD within decades, and eventually expected to eclipse the cost of cancer and heart disease.
Location Denmark
Website brain-plus.com
Founded 2014
Employees 11-50
Industries Healthcare & Life Science, IT & Software
Business model B2C, B2B
Funding state IPO

Working at
Brain+

This job comes with several perks and benefits

Flexible working hours
Flexible working hours

Free coffee / tea
Free coffee / tea

Near public transit
Near public transit

Social gatherings
Social gatherings

Pension plan
Pension plan

Work life balance
Work life balance

See all 10 benefits

Team

KB
CEO

Kim Baden-Kristensen

BP
Marketing & Customer Excellence Manager

Bjarke Panduro

PP
CTO

Paula Petcu